Executive Development Programme in Drug Pricing and Value Creation

Name: Executive Development Programme in Drug Pricing and Value Creation
Availability: InStock

-- viewing now

The Executive Development Programme in Drug Pricing and Value Creation is a certificate course designed to empower professionals with the essential skills needed to navigate the complex landscape of pharmaceutical pricing and value creation. This programme is critical for those who wish to stay competitive in the industry, as it addresses the growing demand for professionals who can effectively price drugs and demonstrate their value to stakeholders.

4.5

Based on 7,200 reviews

4,849+

Students enrolled

GBP £ 140

GBP £ 202

Save 44% with our special offer

Start Now

About this course

Through this course, learners will gain a comprehensive understanding of the drug pricing process, including regulatory requirements, cost drivers, and pricing strategies. They will also develop the ability to evaluate the economic and clinical value of drugs and communicate this value to payers, providers, and patients. By completing this programme, learners will be equipped with the skills and knowledge necessary to advance their careers in the pharmaceutical industry and make a positive impact on healthcare outcomes.

100% online

Learn from anywhere

Shareable certificate

Add to your LinkedIn profile

2 months to complete

at 2-3 hours a week

Start anytime

No waiting period

Course Details

• Introduction to Drug Pricing and Value Creation
• Understanding Pharmaceutical Markets and Pricing Dynamics
• Regulatory Frameworks for Drug Pricing
• Pricing Strategies for Pharmaceutical Products
• Health Economics and Pharmacoeconomics
• Value Assessment in Drug Pricing
• Drug Development and Life Cycle Management
• Global Drug Pricing Trends and Case Studies
• Stakeholder Engagement and Negotiations in Drug Pricing
• Ethical Considerations in Drug Pricing and Value Creation

Career Path

The Executive Development Programme in Drug Pricing and Value Creation focuses on the growing demand for professionals skilled in drug pricing and value creation in the UK. As pharmaceutical companies and healthcare providers navigate complex drug pricing landscapes, employees with expertise in this field are increasingly sought after. This 3D pie chart demonstrates the distribution of job market trends in this sector, with the following roles highlighted: 1. **Pharmacoeconomist**: Representing 35% of the job market, pharmacoeconomists assess the cost-effectiveness of medications and other healthcare interventions. They play a critical role in determining drug pricing and overall healthcare resource allocation. 2. **Health Economist**: With a 25% share, health economists study the economic impact of healthcare policies and treatments. They contribute to drug pricing decisions by evaluating the financial implications of pharmaceutical products on healthcare systems and patients. 3. **Pharmaceutical Pricing Analyst**: Accounting for 20% of the demand, pharmaceutical pricing analysts specialize in analyzing market trends and competitors' pricing strategies. They assist in setting and justifying drug prices and collaborate with cross-functional teams to optimize product value propositions. 4. **Market Access Manager**: A 15% share is held by market access managers, who facilitate the entry and reimbursement of pharmaceutical products in healthcare systems. They bridge the gap between pharmaceutical companies and payers, ensuring patient access and optimizing product value. 5. **Drug Pricing Consultant**: Making up the remaining 5%, drug pricing consultants provide strategic guidance and insights to pharmaceutical companies and healthcare organizations. They address challenges related to drug pricing, market access, and reimbursement, helping clients maximize the value of their products.

Entry Requirements

Basic understanding of the subject matter
Proficiency in English language
Computer and internet access
Basic computer skills
Dedication to complete the course

No prior formal qualifications required. Course designed for accessibility.

Course Status

This course provides practical knowledge and skills for professional development. It is:

Not accredited by a recognized body
Not regulated by an authorized institution
Complementary to formal qualifications

You'll receive a certificate of completion upon successfully finishing the course.

Why people choose us for their career

Loading reviews...

Frequently Asked Questions

What makes this course unique compared to others?

▼

How long does it take to complete the course?

▼

What support will I receive during the course?

▼

Is the certificate recognized internationally?

▼

What career opportunities will this course open up?

▼

When can I start the course?

▼

What is the course format and learning approach?

▼

Course fee

Get course information

Pay as a company

Request an invoice for your company to pay for this course.

Pay by Invoice

Earn a career certificate

EXECUTIVE DEVELOPMENT PROGRAMME IN DRUG PRICING AND VALUE CREATION

is awarded to

Learner Name

who has completed a programme at

London School of International Business (LSIB)

Awarded on

05 May 2025

Blockchain Id: s-1-a-2-m-3-p-4-l-5-e

Add this credential to your LinkedIn profile, resume, or CV. Share it on social media and in your performance review.